Upgrade to SI Premium - Free Trial

Vivani Medical gets ethics approval for semaglutide implant trial

June 25, 2026 7:30 AM
Vivani Medical, Inc. (Nasdaq: VANI) announced it has received approval from Bellberry, a human research ethics committee (HREC) in Australia ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA